THER ADV HEMATOL - Therapeutic Advances in Hematology

Publications

  1. 2023
  2. Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry

    Marchetti, M., Salmanton-García, J., El-Ashwah, S., Verga, L., Itri, F., Ráčil, Z., Dávila-Valls, J., Martín-Pérez, S., Van Doesum, J., Passamonti, F., Abu-Zeinah, G., Farina, F., López-García, A., Dragonetti, G., Cattaneo, C., Gomes Da Silva, M., Bilgin, Y. M., Žák, P., Petzer, V., Glenthøj, A., Espigado, I., Buquicchio, C., Bonuomo, V., Prezioso, L., Meers, S., Duarte, R., Bergantim, R., Jaksic, O., Čolović, N., Blennow, O., Cernan, M., Schönlein, M., Samarkos, M., Mitra, M. E., Magliano, G., Maertens, J., Ledoux, M-P., Jiménez, M., Demirkan, F., Collins, G. P., Cabirta, A., Gräfe, S. K., Nordlander, A., Wolf, D., Arellano, E., Cordoba, R., Hanakova, M., Zambrotta, G. P. M., Nunes Rodrigues, R., Limberti, G., Marchesi, F., Cornely, O. A. & Pagano, L., 2023, In: THER ADV HEMATOL. 14, 20406207231154706.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review